Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis

E. R. Parra, W. Teodoro, J. De Morais, M. Katayama, R. De Souza, N. Yoshinari, V. Luiza (São Paulo, Brazil)

Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Session: Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Session type: Thematic Poster Session
Number: 717
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. R. Parra, W. Teodoro, J. De Morais, M. Katayama, R. De Souza, N. Yoshinari, V. Luiza (São Paulo, Brazil). Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis. Eur Respir J 2009; 34: Suppl. 53, 717

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Up-regulation of collagen type V mRNA in a model of systemic sclerosis
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011

Collagen V nasal tolerance promotes decrease in topoisomerase-1 and pulmonary fibrosis of systemic sclerosis model
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010


Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008


NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021


Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


Pulmonary gene expression of tenascin-C and fibronectin in chronic obtructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

Systemic sclerosis patients‘ sera recognize collagen V in experimental scleroderma lung fibrosis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Increased cytokeratin-19 expression in fibrotic interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010


High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004

High expression of telomerase/endothelin-1 increase replication and activation of vascular myofibroblasts in usual interstitial pneumonia/idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 377s
Year: 2003

Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007


Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009

IGFBP-2: a new pathway in systemic sclerosis associated interstitial lung disease
Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?
Year: 2019



Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002